Onderzoeker
Kathleen Lambein
- Trefwoorden:Geneeskunde
- Disciplines:Morfologische wetenschappen, Oncologie, Orthopedie, Heelkunde, Verpleegkunde
Affiliaties
- Oncologische Heelkunde (Afdeling)
Lid
Vanaf15 mrt 2015 → Heden
Projecten
1 - 1 of 1
- Rol van gecombineerde chemo- en immunotherapie in vroegtijdige stadia van borstkanker.Vanaf1 okt 2016 → 30 sep 2020Financiering: VZW en equivalenten
Publicaties
1 - 10 van 28
- Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study(2023)
Auteurs: Kathleen Lambein
- Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast(2022)
Auteurs: Kathleen Lambein
Pagina's: 367 - 375 - Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study(2021)
Auteurs: Beppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pagina's: 2130 - 2140 - Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Auteurs: Hanne Vos, Kathleen Lambein, François Richard, Ines Nevelsteen, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Beppe Floris, Christine Desmedt, et al.
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)
Auteurs: Ayse Bassez, Hanne Vos, Laurien Van Dyck, Beppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein, et al.
Pagina's: 820 - + - Immune-related adverse events after a single dose of pembrolizumab(2021)
Auteurs: Hanne Vos, Kathleen Lambein, Hans Wildiers, Kevin Punie, Ann Smeets
Pagina's: 92 - 94 - Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study(2020)
Auteurs: Beppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pagina's: 354 - 366 - Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.(2019)
Auteurs: Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Rose Christiaens, Chantal Van Ongeval, Hans Wildiers, et al.
Pagina's: 550 - 559 - HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?(2019)
Auteurs: Kathleen Lambein, Louis Libbrecht
Pagina's: 666 - 668 - Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance(2018)
Auteurs: Marcella Baldewijns, Beppe Floris, Kathleen Lambein, Anne-Sophie Van Rompuy
Pagina's: 923 - 932